πŸ‡ΊπŸ‡Έ FDA
Patent

US 9233926

Compounds for stem cell differentiation

granted A61KA61K31/47A61K31/4709

Quick answer

US patent 9233926 (Compounds for stem cell differentiation) held by ChemRegen, Inc. expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ChemRegen, Inc.
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/47, A61K31/4709, A61K31/475, A61K38/1841